$PHG

Koninklijke Philips ADR earnings beat by $0.06, revenue fell short of estimates

Koninklijke Philips ADR (PHG) reported Q3 EPS of $0.45, beating estimates by $0.06, but revenue of $4.99B missed expectations. The stock is up 4.79% over 3 months but down 1.53% over 12 months. InvestingPro rates its financial health as 'great performance.'

Original reporting
Published Nov 3, 2026, 6:47 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 6:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PHG
Bearish
high confidence
Mentioned
$PHG
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PHGBearishMed
01

Why it matters

The mixed results provide a nuanced view: profit beat versus revenue shortfall, suggesting short‑term volatility.

02

Market read

Earnings release is the primary driver of relevance; no broader macro or sector event.

03

What to watch

Geographic revenue mix and upcoming product launches may offset the near‑term revenue miss.

Relevance 7/10Novelty 8/10Timing: after-hours release

Background

Philips (NYSE: PHG) released its third‑quarter results, a routine earnings disclosure.

Company-level read

Ticker impact

$PHGBearishHigh confidence
Context

Philips reported Q3 EPS of $0.45, beating estimates by $0.06, while revenue missed by $30M.

Expected impact

likely pressure as investors price in the revenue shortfall despite EPS beat

Evidence & confidence

The EPS surprise is modest and the revenue miss signals weaker demand, which typically leads to a near‑term pullback.

Market effects

May signal softening in health‑tech equipment demand, affecting peers.

European health‑tech stocks could see modest downside.

Limited to Philips and its direct competitors.

Counterpoint

The EPS beat could be a catalyst for a short‑term rally if investors focus on profitability.

Key entities

  • Philips

    Global health‑technology and consumer‑goods company.

Related articles

$PHGHigh

Why is Koninklijke Philips stock rallying today?

Koninklijke Philips (PHG) stock rose 5.6% to €25.90 after Q3 2026 results beat expectations, with 8% order intake growth and 3% sales growth. Adjusted EBITA margin expanded to 13.0%, and free cash flow reached €384M. The company reaffirmed its annual outlook, despite a net income drop due to a €288M legal provision. Analysts maintained a 'Hold' consensus.

$PHGMedAI 8/10

Royal Philips: Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated

Royal Philips reported Q3 2026 results with 8% comparable order intake growth and 3% comparable sales growth, reaching EUR 4.4 billion. Adjusted EBITA margin expanded to 13.0%. The company reiterated its 2026 outlook and announced a settlement agreement with the US DOJ regarding Respironics recall investigations.

$PHGMedAI 8/10

Philips Q3 adjusted earnings rise as order intake strengthens

Philips reported Q3 adjusted earnings growth, with comparable sales up 3% to €4.39B and adjusted EBITA up to €569M. Net income fell to €28M due to a €288M provision. Sales growth was led by Personal Health and Connected Care. The company reiterated its 2026 outlook, including sales growth of 3-4.5% and adjusted EBITA margin of 13.5-14.0%.

$PHGHighAI 8/10

Ontario picked a Philips system to share over 20 million medical scans a year

Royal Philips reported Q3 2026 sales of EUR 4.4B, up 3%, with an adjusted EBITA margin of 13.0%. The company secured a major contract with Ontario Health for medical scans. Philips also reached an agreement in principle with the US DOJ regarding Respironics recall investigations, recording a EUR 288M provision. The company reiterated its full-year 2026 outlook and announced a EUR 650M green bond issuance.